BioSig Technologies, Inc.
BioSig Technologies, Inc. BSGM Peers
See (BSGM) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Devices Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| BSGM | $9.65 | +15.99% | 266.1M | -18.40 | -$0.53 | N/A |
| ABT | $134.11 | -1.58% | 233.3B | 17.43 | $7.69 | +1.69% |
| BSX-PA | $122.18 | +2.37% | 175.4B | 230.53 | $0.53 | N/A |
| BSX | $103.63 | -1.10% | 153.3B | 75.64 | $1.37 | N/A |
| SYK | $391.81 | -1.24% | 149.7B | 53.01 | $7.39 | +0.85% |
| MDT | $88.28 | -0.53% | 113.2B | 24.47 | $3.61 | +3.18% |
| EW | $77.02 | -0.21% | 45.2B | 31.82 | $2.42 | N/A |
| DXCM | $83.58 | +0.01% | 32.8B | 62.83 | $1.33 | N/A |
| STE | $238.25 | -1.82% | 23.4B | 38.67 | $6.16 | +0.96% |
| PHG | $24.52 | +1.32% | 22.7B | 81.80 | $0.30 | +3.61% |
Stock Comparison
BSGM vs ABT Comparison
BSGM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 266.1M. In comparison, ABT has a market cap of 233.3B. Regarding current trading prices, BSGM is priced at $9.65, while ABT trades at $134.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -18.40, whereas ABT's P/E ratio is 17.43. In terms of profitability, BSGM's ROE is -35.30%, compared to ABT's ROE of +0.31%. Regarding short-term risk, BSGM is more volatile compared to ABT. This indicates potentially higher risk in terms of short-term price fluctuations for BSGM.
BSGM vs BSX-PA Comparison
BSGM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 266.1M. In comparison, BSX-PA has a market cap of 175.4B. Regarding current trading prices, BSGM is priced at $9.65, while BSX-PA trades at $122.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -18.40, whereas BSX-PA's P/E ratio is 230.53. In terms of profitability, BSGM's ROE is -35.30%, compared to BSX-PA's ROE of +0.10%. Regarding short-term risk, BSGM is more volatile compared to BSX-PA. This indicates potentially higher risk in terms of short-term price fluctuations for BSGM.
BSGM vs BSX Comparison
BSGM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 266.1M. In comparison, BSX has a market cap of 153.3B. Regarding current trading prices, BSGM is priced at $9.65, while BSX trades at $103.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -18.40, whereas BSX's P/E ratio is 75.64. In terms of profitability, BSGM's ROE is -35.30%, compared to BSX's ROE of +0.10%. Regarding short-term risk, BSGM is more volatile compared to BSX. This indicates potentially higher risk in terms of short-term price fluctuations for BSGM.
BSGM vs SYK Comparison
BSGM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 266.1M. In comparison, SYK has a market cap of 149.7B. Regarding current trading prices, BSGM is priced at $9.65, while SYK trades at $391.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -18.40, whereas SYK's P/E ratio is 53.01. In terms of profitability, BSGM's ROE is -35.30%, compared to SYK's ROE of +0.11%. Regarding short-term risk, BSGM is more volatile compared to SYK. This indicates potentially higher risk in terms of short-term price fluctuations for BSGM.
BSGM vs MDT Comparison
BSGM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 266.1M. In comparison, MDT has a market cap of 113.2B. Regarding current trading prices, BSGM is priced at $9.65, while MDT trades at $88.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -18.40, whereas MDT's P/E ratio is 24.47. In terms of profitability, BSGM's ROE is -35.30%, compared to MDT's ROE of +0.10%. Regarding short-term risk, BSGM is more volatile compared to MDT. This indicates potentially higher risk in terms of short-term price fluctuations for BSGM.
BSGM vs EW Comparison
BSGM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 266.1M. In comparison, EW has a market cap of 45.2B. Regarding current trading prices, BSGM is priced at $9.65, while EW trades at $77.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -18.40, whereas EW's P/E ratio is 31.82. In terms of profitability, BSGM's ROE is -35.30%, compared to EW's ROE of +0.49%. Regarding short-term risk, BSGM is more volatile compared to EW. This indicates potentially higher risk in terms of short-term price fluctuations for BSGM.
BSGM vs DXCM Comparison
BSGM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 266.1M. In comparison, DXCM has a market cap of 32.8B. Regarding current trading prices, BSGM is priced at $9.65, while DXCM trades at $83.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -18.40, whereas DXCM's P/E ratio is 62.83. In terms of profitability, BSGM's ROE is -35.30%, compared to DXCM's ROE of +0.24%. Regarding short-term risk, BSGM is more volatile compared to DXCM. This indicates potentially higher risk in terms of short-term price fluctuations for BSGM.
BSGM vs STE Comparison
BSGM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 266.1M. In comparison, STE has a market cap of 23.4B. Regarding current trading prices, BSGM is priced at $9.65, while STE trades at $238.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -18.40, whereas STE's P/E ratio is 38.67. In terms of profitability, BSGM's ROE is -35.30%, compared to STE's ROE of +0.09%. Regarding short-term risk, BSGM is more volatile compared to STE. This indicates potentially higher risk in terms of short-term price fluctuations for BSGM.
BSGM vs PHG Comparison
BSGM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 266.1M. In comparison, PHG has a market cap of 22.7B. Regarding current trading prices, BSGM is priced at $9.65, while PHG trades at $24.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -18.40, whereas PHG's P/E ratio is 81.80. In terms of profitability, BSGM's ROE is -35.30%, compared to PHG's ROE of +0.03%. Regarding short-term risk, BSGM is more volatile compared to PHG. This indicates potentially higher risk in terms of short-term price fluctuations for BSGM.
BSGM vs PODD Comparison
BSGM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 266.1M. In comparison, PODD has a market cap of 21.2B. Regarding current trading prices, BSGM is priced at $9.65, while PODD trades at $301.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -18.40, whereas PODD's P/E ratio is 54.32. In terms of profitability, BSGM's ROE is -35.30%, compared to PODD's ROE of +0.35%. Regarding short-term risk, BSGM is more volatile compared to PODD. This indicates potentially higher risk in terms of short-term price fluctuations for BSGM.
BSGM vs ZBH Comparison
BSGM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 266.1M. In comparison, ZBH has a market cap of 18.5B. Regarding current trading prices, BSGM is priced at $9.65, while ZBH trades at $93.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -18.40, whereas ZBH's P/E ratio is 20.79. In terms of profitability, BSGM's ROE is -35.30%, compared to ZBH's ROE of +0.07%. Regarding short-term risk, BSGM is more volatile compared to ZBH. This indicates potentially higher risk in terms of short-term price fluctuations for BSGM.
BSGM vs ABMD Comparison
BSGM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 266.1M. In comparison, ABMD has a market cap of 17.2B. Regarding current trading prices, BSGM is priced at $9.65, while ABMD trades at $381.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -18.40, whereas ABMD's P/E ratio is 65.36. In terms of profitability, BSGM's ROE is -35.30%, compared to ABMD's ROE of +0.10%. Regarding short-term risk, BSGM is more volatile compared to ABMD. This indicates potentially higher risk in terms of short-term price fluctuations for BSGM.
BSGM vs ALGN Comparison
BSGM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 266.1M. In comparison, ALGN has a market cap of 14.3B. Regarding current trading prices, BSGM is priced at $9.65, while ALGN trades at $196.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -18.40, whereas ALGN's P/E ratio is 35.75. In terms of profitability, BSGM's ROE is -35.30%, compared to ALGN's ROE of +0.11%. Regarding short-term risk, BSGM is more volatile compared to ALGN. This indicates potentially higher risk in terms of short-term price fluctuations for BSGM.
BSGM vs SNN Comparison
BSGM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 266.1M. In comparison, SNN has a market cap of 13.2B. Regarding current trading prices, BSGM is priced at $9.65, while SNN trades at $30.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -18.40, whereas SNN's P/E ratio is 32.09. In terms of profitability, BSGM's ROE is -35.30%, compared to SNN's ROE of +0.08%. Regarding short-term risk, BSGM is more volatile compared to SNN. This indicates potentially higher risk in terms of short-term price fluctuations for BSGM.
BSGM vs SWAV Comparison
BSGM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 266.1M. In comparison, SWAV has a market cap of 12.6B. Regarding current trading prices, BSGM is priced at $9.65, while SWAV trades at $334.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -18.40, whereas SWAV's P/E ratio is 78.76. In terms of profitability, BSGM's ROE is -35.30%, compared to SWAV's ROE of +0.14%. Regarding short-term risk, BSGM is more volatile compared to SWAV. This indicates potentially higher risk in terms of short-term price fluctuations for BSGM.
BSGM vs PEN Comparison
BSGM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 266.1M. In comparison, PEN has a market cap of 9.7B. Regarding current trading prices, BSGM is priced at $9.65, while PEN trades at $249.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -18.40, whereas PEN's P/E ratio is 231.24. In terms of profitability, BSGM's ROE is -35.30%, compared to PEN's ROE of +0.04%. Regarding short-term risk, BSGM is more volatile compared to PEN. This indicates potentially higher risk in terms of short-term price fluctuations for BSGM.
BSGM vs GMED Comparison
BSGM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 266.1M. In comparison, GMED has a market cap of 8.2B. Regarding current trading prices, BSGM is priced at $9.65, while GMED trades at $60.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -18.40, whereas GMED's P/E ratio is 45.19. In terms of profitability, BSGM's ROE is -35.30%, compared to GMED's ROE of +0.05%. Regarding short-term risk, BSGM is more volatile compared to GMED. This indicates potentially higher risk in terms of short-term price fluctuations for BSGM.
BSGM vs BIO Comparison
BSGM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 266.1M. In comparison, BIO has a market cap of 6.8B. Regarding current trading prices, BSGM is priced at $9.65, while BIO trades at $250.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -18.40, whereas BIO's P/E ratio is -3.27. In terms of profitability, BSGM's ROE is -35.30%, compared to BIO's ROE of -0.32%. Regarding short-term risk, BSGM is more volatile compared to BIO. This indicates potentially higher risk in terms of short-term price fluctuations for BSGM.
BSGM vs BIO-B Comparison
BSGM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 266.1M. In comparison, BIO-B has a market cap of 6.8B. Regarding current trading prices, BSGM is priced at $9.65, while BIO-B trades at $250.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -18.40, whereas BIO-B's P/E ratio is -3.27. In terms of profitability, BSGM's ROE is -35.30%, compared to BIO-B's ROE of -0.32%. Regarding short-term risk, BSGM is more volatile compared to BIO-B. This indicates potentially higher risk in terms of short-term price fluctuations for BSGM.
BSGM vs BRKR Comparison
BSGM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 266.1M. In comparison, BRKR has a market cap of 6.4B. Regarding current trading prices, BSGM is priced at $9.65, while BRKR trades at $42.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -18.40, whereas BRKR's P/E ratio is 81.67. In terms of profitability, BSGM's ROE is -35.30%, compared to BRKR's ROE of +0.04%. Regarding short-term risk, BSGM is more volatile compared to BRKR. This indicates potentially higher risk in terms of short-term price fluctuations for BSGM.
BSGM vs GKOS Comparison
BSGM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 266.1M. In comparison, GKOS has a market cap of 5.9B. Regarding current trading prices, BSGM is priced at $9.65, while GKOS trades at $103.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -18.40, whereas GKOS's P/E ratio is -45.66. In terms of profitability, BSGM's ROE is -35.30%, compared to GKOS's ROE of -0.17%. Regarding short-term risk, BSGM is more volatile compared to GKOS. This indicates potentially higher risk in terms of short-term price fluctuations for BSGM.
BSGM vs NARI Comparison
BSGM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 266.1M. In comparison, NARI has a market cap of 4.7B. Regarding current trading prices, BSGM is priced at $9.65, while NARI trades at $79.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -18.40, whereas NARI's P/E ratio is -59.24. In terms of profitability, BSGM's ROE is -35.30%, compared to NARI's ROE of -0.18%. Regarding short-term risk, BSGM is more volatile compared to NARI. This indicates potentially higher risk in terms of short-term price fluctuations for BSGM.
BSGM vs IRTC Comparison
BSGM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 266.1M. In comparison, IRTC has a market cap of 4.6B. Regarding current trading prices, BSGM is priced at $9.65, while IRTC trades at $142.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -18.40, whereas IRTC's P/E ratio is -45.76. In terms of profitability, BSGM's ROE is -35.30%, compared to IRTC's ROE of -1.13%. Regarding short-term risk, BSGM is more volatile compared to IRTC. This indicates potentially higher risk in terms of short-term price fluctuations for BSGM.
BSGM vs TMDX Comparison
BSGM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 266.1M. In comparison, TMDX has a market cap of 4.3B. Regarding current trading prices, BSGM is priced at $9.65, while TMDX trades at $127.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -18.40, whereas TMDX's P/E ratio is 89.85. In terms of profitability, BSGM's ROE is -35.30%, compared to TMDX's ROE of +0.22%. Regarding short-term risk, BSGM is more volatile compared to TMDX. This indicates potentially higher risk in terms of short-term price fluctuations for BSGM.
BSGM vs ITGR Comparison
BSGM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 266.1M. In comparison, ITGR has a market cap of 4.2B. Regarding current trading prices, BSGM is priced at $9.65, while ITGR trades at $121.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -18.40, whereas ITGR's P/E ratio is 56.66. In terms of profitability, BSGM's ROE is -35.30%, compared to ITGR's ROE of +0.05%. Regarding short-term risk, BSGM is more volatile compared to ITGR. This indicates potentially higher risk in terms of short-term price fluctuations for BSGM.
BSGM vs INSP Comparison
BSGM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 266.1M. In comparison, INSP has a market cap of 3.8B. Regarding current trading prices, BSGM is priced at $9.65, while INSP trades at $130.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -18.40, whereas INSP's P/E ratio is 59.59. In terms of profitability, BSGM's ROE is -35.30%, compared to INSP's ROE of +0.10%. Regarding short-term risk, BSGM is more volatile compared to INSP. This indicates potentially higher risk in terms of short-term price fluctuations for BSGM.
BSGM vs AXNX Comparison
BSGM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 266.1M. In comparison, AXNX has a market cap of 3.6B. Regarding current trading prices, BSGM is priced at $9.65, while AXNX trades at $70.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -18.40, whereas AXNX's P/E ratio is -709.80. In terms of profitability, BSGM's ROE is -35.30%, compared to AXNX's ROE of -0.01%. Regarding short-term risk, BSGM is more volatile compared to AXNX. This indicates potentially higher risk in terms of short-term price fluctuations for BSGM.
BSGM vs PRCT Comparison
BSGM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 266.1M. In comparison, PRCT has a market cap of 3.2B. Regarding current trading prices, BSGM is priced at $9.65, while PRCT trades at $58.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -18.40, whereas PRCT's P/E ratio is -34.41. In terms of profitability, BSGM's ROE is -35.30%, compared to PRCT's ROE of -0.28%. Regarding short-term risk, BSGM is more volatile compared to PRCT. This indicates potentially higher risk in terms of short-term price fluctuations for BSGM.
BSGM vs LIVN Comparison
BSGM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 266.1M. In comparison, LIVN has a market cap of 2.5B. Regarding current trading prices, BSGM is priced at $9.65, while LIVN trades at $46.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -18.40, whereas LIVN's P/E ratio is -11.33. In terms of profitability, BSGM's ROE is -35.30%, compared to LIVN's ROE of -0.18%. Regarding short-term risk, BSGM is more volatile compared to LIVN. This indicates potentially higher risk in terms of short-term price fluctuations for BSGM.
BSGM vs NUVA Comparison
BSGM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 266.1M. In comparison, NUVA has a market cap of 2.1B. Regarding current trading prices, BSGM is priced at $9.65, while NUVA trades at $39.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -18.40, whereas NUVA's P/E ratio is 75.00. In terms of profitability, BSGM's ROE is -35.30%, compared to NUVA's ROE of +0.05%. Regarding short-term risk, BSGM is more volatile compared to NUVA. This indicates potentially higher risk in terms of short-term price fluctuations for BSGM.
BSGM vs UFPT Comparison
BSGM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 266.1M. In comparison, UFPT has a market cap of 1.9B. Regarding current trading prices, BSGM is priced at $9.65, while UFPT trades at $245.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -18.40, whereas UFPT's P/E ratio is 30.12. In terms of profitability, BSGM's ROE is -35.30%, compared to UFPT's ROE of +0.19%. Regarding short-term risk, BSGM is more volatile compared to UFPT. This indicates potentially higher risk in terms of short-term price fluctuations for BSGM.
BSGM vs CNMD Comparison
BSGM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 266.1M. In comparison, CNMD has a market cap of 1.7B. Regarding current trading prices, BSGM is priced at $9.65, while CNMD trades at $54.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -18.40, whereas CNMD's P/E ratio is 14.23. In terms of profitability, BSGM's ROE is -35.30%, compared to CNMD's ROE of +0.13%. Regarding short-term risk, BSGM is more volatile compared to CNMD. This indicates potentially higher risk in terms of short-term price fluctuations for BSGM.
BSGM vs ATEC Comparison
BSGM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 266.1M. In comparison, ATEC has a market cap of 1.6B. Regarding current trading prices, BSGM is priced at $9.65, while ATEC trades at $10.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -18.40, whereas ATEC's P/E ratio is -9.62. In terms of profitability, BSGM's ROE is -35.30%, compared to ATEC's ROE of -2.58%. Regarding short-term risk, BSGM is more volatile compared to ATEC. This indicates potentially higher risk in terms of short-term price fluctuations for BSGM.
BSGM vs AORT Comparison
BSGM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 266.1M. In comparison, AORT has a market cap of 1.3B. Regarding current trading prices, BSGM is priced at $9.65, while AORT trades at $30.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -18.40, whereas AORT's P/E ratio is -60.55. In terms of profitability, BSGM's ROE is -35.30%, compared to AORT's ROE of -0.07%. Regarding short-term risk, BSGM is more volatile compared to AORT. This indicates potentially higher risk in terms of short-term price fluctuations for BSGM.
BSGM vs HSKA Comparison
BSGM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 266.1M. In comparison, HSKA has a market cap of 1.3B. Regarding current trading prices, BSGM is priced at $9.65, while HSKA trades at $119.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -18.40, whereas HSKA's P/E ratio is -62.49. In terms of profitability, BSGM's ROE is -35.30%, compared to HSKA's ROE of -0.04%. Regarding short-term risk, BSGM is more volatile compared to HSKA. This indicates potentially higher risk in terms of short-term price fluctuations for BSGM.
BSGM vs ESTA Comparison
BSGM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 266.1M. In comparison, ESTA has a market cap of 1.3B. Regarding current trading prices, BSGM is priced at $9.65, while ESTA trades at $44.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -18.40, whereas ESTA's P/E ratio is -14.19. In terms of profitability, BSGM's ROE is -35.30%, compared to ESTA's ROE of -2.10%. Regarding short-term risk, BSGM is more volatile compared to ESTA. This indicates potentially higher risk in terms of short-term price fluctuations for BSGM.
BSGM vs AHCO Comparison
BSGM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 266.1M. In comparison, AHCO has a market cap of 1.3B. Regarding current trading prices, BSGM is priced at $9.65, while AHCO trades at $9.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -18.40, whereas AHCO's P/E ratio is 16.15. In terms of profitability, BSGM's ROE is -35.30%, compared to AHCO's ROE of +0.06%. Regarding short-term risk, BSGM is more volatile compared to AHCO. This indicates potentially higher risk in terms of short-term price fluctuations for BSGM.
BSGM vs TNDM Comparison
BSGM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 266.1M. In comparison, TNDM has a market cap of 1.1B. Regarding current trading prices, BSGM is priced at $9.65, while TNDM trades at $17.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -18.40, whereas TNDM's P/E ratio is -6.12. In terms of profitability, BSGM's ROE is -35.30%, compared to TNDM's ROE of -0.83%. Regarding short-term risk, BSGM is more volatile compared to TNDM. This indicates potentially higher risk in terms of short-term price fluctuations for BSGM.
BSGM vs SILK Comparison
BSGM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 266.1M. In comparison, SILK has a market cap of 1.1B. Regarding current trading prices, BSGM is priced at $9.65, while SILK trades at $27.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -18.40, whereas SILK's P/E ratio is -18.96. In terms of profitability, BSGM's ROE is -35.30%, compared to SILK's ROE of -0.29%. Regarding short-term risk, BSGM is more volatile compared to SILK. This indicates potentially higher risk in terms of short-term price fluctuations for BSGM.
BSGM vs FNA Comparison
BSGM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 266.1M. In comparison, FNA has a market cap of 1.1B. Regarding current trading prices, BSGM is priced at $9.65, while FNA trades at $13.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -18.40, whereas FNA's P/E ratio is -19.83. In terms of profitability, BSGM's ROE is -35.30%, compared to FNA's ROE of -0.36%. Regarding short-term risk, BSGM is more volatile compared to FNA. This indicates potentially higher risk in terms of short-term price fluctuations for BSGM.
BSGM vs INMD Comparison
BSGM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 266.1M. In comparison, INMD has a market cap of 1.1B. Regarding current trading prices, BSGM is priced at $9.65, while INMD trades at $15.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -18.40, whereas INMD's P/E ratio is 6.82. In terms of profitability, BSGM's ROE is -35.30%, compared to INMD's ROE of +0.25%. Regarding short-term risk, BSGM is more volatile compared to INMD. This indicates potentially higher risk in terms of short-term price fluctuations for BSGM.
BSGM vs IART Comparison
BSGM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 266.1M. In comparison, IART has a market cap of 1B. Regarding current trading prices, BSGM is priced at $9.65, while IART trades at $13.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -18.40, whereas IART's P/E ratio is -35.55. In terms of profitability, BSGM's ROE is -35.30%, compared to IART's ROE of -0.03%. Regarding short-term risk, BSGM is more volatile compared to IART. This indicates potentially higher risk in terms of short-term price fluctuations for BSGM.
BSGM vs SSII Comparison
BSGM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 266.1M. In comparison, SSII has a market cap of 1B. Regarding current trading prices, BSGM is priced at $9.65, while SSII trades at $5.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -18.40, whereas SSII's P/E ratio is -65.37. In terms of profitability, BSGM's ROE is -35.30%, compared to SSII's ROE of -1.33%. Regarding short-term risk, BSGM is more volatile compared to SSII. This indicates potentially higher risk in terms of short-term price fluctuations for BSGM.
BSGM vs CSII Comparison
BSGM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 266.1M. In comparison, CSII has a market cap of 844M. Regarding current trading prices, BSGM is priced at $9.65, while CSII trades at $20.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -18.40, whereas CSII's P/E ratio is -20.83. In terms of profitability, BSGM's ROE is -35.30%, compared to CSII's ROE of -0.14%. Regarding short-term risk, BSGM is more volatile compared to CSII. This indicates potentially higher risk in terms of short-term price fluctuations for BSGM.
BSGM vs SIBN Comparison
BSGM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 266.1M. In comparison, SIBN has a market cap of 785.2M. Regarding current trading prices, BSGM is priced at $9.65, while SIBN trades at $18.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -18.40, whereas SIBN's P/E ratio is -29.25. In terms of profitability, BSGM's ROE is -35.30%, compared to SIBN's ROE of -0.16%. Regarding short-term risk, BSGM is more volatile compared to SIBN. This indicates potentially higher risk in terms of short-term price fluctuations for BSGM.
BSGM vs IRMD Comparison
BSGM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 266.1M. In comparison, IRMD has a market cap of 782.5M. Regarding current trading prices, BSGM is priced at $9.65, while IRMD trades at $61.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -18.40, whereas IRMD's P/E ratio is 39.70. In terms of profitability, BSGM's ROE is -35.30%, compared to IRMD's ROE of +0.23%. Regarding short-term risk, BSGM is more volatile compared to IRMD. This indicates potentially higher risk in terms of short-term price fluctuations for BSGM.
BSGM vs CRY Comparison
BSGM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 266.1M. In comparison, CRY has a market cap of 725.1M. Regarding current trading prices, BSGM is priced at $9.65, while CRY trades at $17.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -18.40, whereas CRY's P/E ratio is 425.71. In terms of profitability, BSGM's ROE is -35.30%, compared to CRY's ROE of -0.07%. Regarding short-term risk, BSGM is more volatile compared to CRY. This indicates potentially higher risk in terms of short-term price fluctuations for BSGM.
BSGM vs CBLL Comparison
BSGM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 266.1M. In comparison, CBLL has a market cap of 674.1M. Regarding current trading prices, BSGM is priced at $9.65, while CBLL trades at $18.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -18.40, whereas CBLL's P/E ratio is -14.92. In terms of profitability, BSGM's ROE is -35.30%, compared to CBLL's ROE of -1.64%. Regarding short-term risk, BSGM is more volatile compared to CBLL. This indicates potentially higher risk in terms of short-term price fluctuations for BSGM.
BSGM vs BFLY-WT Comparison
BSGM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 266.1M. In comparison, BFLY-WT has a market cap of 580.6M. Regarding current trading prices, BSGM is priced at $9.65, while BFLY-WT trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -18.40, whereas BFLY-WT's P/E ratio is N/A. In terms of profitability, BSGM's ROE is -35.30%, compared to BFLY-WT's ROE of -0.33%. Regarding short-term risk, BSGM is more volatile compared to BFLY-WT. This indicates potentially higher risk in terms of short-term price fluctuations for BSGM.
BSGM vs APEN Comparison
BSGM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 266.1M. In comparison, APEN has a market cap of 579.7M. Regarding current trading prices, BSGM is priced at $9.65, while APEN trades at $10.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -18.40, whereas APEN's P/E ratio is -9.43. In terms of profitability, BSGM's ROE is -35.30%, compared to APEN's ROE of -0.85%. Regarding short-term risk, BSGM is more volatile compared to APEN. This indicates potentially higher risk in terms of short-term price fluctuations for BSGM.
BSGM vs AVNS Comparison
BSGM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 266.1M. In comparison, AVNS has a market cap of 570.9M. Regarding current trading prices, BSGM is priced at $9.65, while AVNS trades at $12.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -18.40, whereas AVNS's P/E ratio is -1.49. In terms of profitability, BSGM's ROE is -35.30%, compared to AVNS's ROE of -0.37%. Regarding short-term risk, BSGM is more volatile compared to AVNS. This indicates potentially higher risk in terms of short-term price fluctuations for BSGM.
BSGM vs KIDS Comparison
BSGM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 266.1M. In comparison, KIDS has a market cap of 549.1M. Regarding current trading prices, BSGM is priced at $9.65, while KIDS trades at $22.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -18.40, whereas KIDS's P/E ratio is -12.60. In terms of profitability, BSGM's ROE is -35.30%, compared to KIDS's ROE of -0.11%. Regarding short-term risk, BSGM is more volatile compared to KIDS. This indicates potentially higher risk in terms of short-term price fluctuations for BSGM.
BSGM vs RXST Comparison
BSGM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 266.1M. In comparison, RXST has a market cap of 533.6M. Regarding current trading prices, BSGM is priced at $9.65, while RXST trades at $13.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -18.40, whereas RXST's P/E ratio is -19.89. In terms of profitability, BSGM's ROE is -35.30%, compared to RXST's ROE of -0.10%. Regarding short-term risk, BSGM is more volatile compared to RXST. This indicates potentially higher risk in terms of short-term price fluctuations for BSGM.
BSGM vs AXGN Comparison
BSGM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 266.1M. In comparison, AXGN has a market cap of 503.7M. Regarding current trading prices, BSGM is priced at $9.65, while AXGN trades at $11.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -18.40, whereas AXGN's P/E ratio is -69.12. In terms of profitability, BSGM's ROE is -35.30%, compared to AXGN's ROE of -0.07%. Regarding short-term risk, BSGM is more volatile compared to AXGN. This indicates potentially higher risk in terms of short-term price fluctuations for BSGM.
BSGM vs BFLY Comparison
BSGM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 266.1M. In comparison, BFLY has a market cap of 485.9M. Regarding current trading prices, BSGM is priced at $9.65, while BFLY trades at $1.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -18.40, whereas BFLY's P/E ratio is -6.55. In terms of profitability, BSGM's ROE is -35.30%, compared to BFLY's ROE of -0.33%. Regarding short-term risk, BSGM is more volatile compared to BFLY. This indicates potentially higher risk in terms of short-term price fluctuations for BSGM.
BSGM vs CTKB Comparison
BSGM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 266.1M. In comparison, CTKB has a market cap of 456.6M. Regarding current trading prices, BSGM is priced at $9.65, while CTKB trades at $3.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -18.40, whereas CTKB's P/E ratio is -40.06. In terms of profitability, BSGM's ROE is -35.30%, compared to CTKB's ROE of -0.03%. Regarding short-term risk, BSGM is more volatile compared to CTKB. This indicates potentially higher risk in terms of short-term price fluctuations for BSGM.
BSGM vs BVS Comparison
BSGM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 266.1M. In comparison, BVS has a market cap of 454.2M. Regarding current trading prices, BSGM is priced at $9.65, while BVS trades at $6.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -18.40, whereas BVS's P/E ratio is -14.26. In terms of profitability, BSGM's ROE is -35.30%, compared to BVS's ROE of -0.21%. Regarding short-term risk, BSGM is more volatile compared to BVS. This indicates potentially higher risk in terms of short-term price fluctuations for BSGM.
BSGM vs PACB Comparison
BSGM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 266.1M. In comparison, PACB has a market cap of 445.6M. Regarding current trading prices, BSGM is priced at $9.65, while PACB trades at $1.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -18.40, whereas PACB's P/E ratio is -0.54. In terms of profitability, BSGM's ROE is -35.30%, compared to PACB's ROE of -1.70%. Regarding short-term risk, BSGM is more volatile compared to PACB. This indicates potentially higher risk in terms of short-term price fluctuations for BSGM.
BSGM vs SMLR Comparison
BSGM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 266.1M. In comparison, SMLR has a market cap of 441.2M. Regarding current trading prices, BSGM is priced at $9.65, while SMLR trades at $39.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -18.40, whereas SMLR's P/E ratio is -16.55. In terms of profitability, BSGM's ROE is -35.30%, compared to SMLR's ROE of -0.21%. Regarding short-term risk, BSGM is more volatile compared to SMLR. This indicates potentially higher risk in terms of short-term price fluctuations for BSGM.
BSGM vs OFIX Comparison
BSGM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 266.1M. In comparison, OFIX has a market cap of 433.3M. Regarding current trading prices, BSGM is priced at $9.65, while OFIX trades at $11.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -18.40, whereas OFIX's P/E ratio is -2.99. In terms of profitability, BSGM's ROE is -35.30%, compared to OFIX's ROE of -0.28%. Regarding short-term risk, BSGM is more volatile compared to OFIX. This indicates potentially higher risk in terms of short-term price fluctuations for BSGM.
BSGM vs SRDX Comparison
BSGM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 266.1M. In comparison, SRDX has a market cap of 414M. Regarding current trading prices, BSGM is priced at $9.65, while SRDX trades at $29.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -18.40, whereas SRDX's P/E ratio is -20.68. In terms of profitability, BSGM's ROE is -35.30%, compared to SRDX's ROE of -0.17%. Regarding short-term risk, BSGM is more volatile compared to SRDX. This indicates potentially higher risk in terms of short-term price fluctuations for BSGM.
BSGM vs TMCI Comparison
BSGM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 266.1M. In comparison, TMCI has a market cap of 383.7M. Regarding current trading prices, BSGM is priced at $9.65, while TMCI trades at $6.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -18.40, whereas TMCI's P/E ratio is -7.18. In terms of profitability, BSGM's ROE is -35.30%, compared to TMCI's ROE of -0.49%. Regarding short-term risk, BSGM is more volatile compared to TMCI. This indicates potentially higher risk in terms of short-term price fluctuations for BSGM.
BSGM vs SENS Comparison
BSGM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 266.1M. In comparison, SENS has a market cap of 374.7M. Regarding current trading prices, BSGM is priced at $9.65, while SENS trades at $0.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -18.40, whereas SENS's P/E ratio is -4.52. In terms of profitability, BSGM's ROE is -35.30%, compared to SENS's ROE of -7.46%. Regarding short-term risk, BSGM is more volatile compared to SENS. This indicates potentially higher risk in terms of short-term price fluctuations for BSGM.
BSGM vs OM Comparison
BSGM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 266.1M. In comparison, OM has a market cap of 364.2M. Regarding current trading prices, BSGM is priced at $9.65, while OM trades at $20.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -18.40, whereas OM's P/E ratio is -0.71. In terms of profitability, BSGM's ROE is -35.30%, compared to OM's ROE of -1.45%. Regarding short-term risk, BSGM is more volatile compared to OM. This indicates potentially higher risk in terms of short-term price fluctuations for BSGM.
BSGM vs VREX Comparison
BSGM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 266.1M. In comparison, VREX has a market cap of 361.5M. Regarding current trading prices, BSGM is priced at $9.65, while VREX trades at $8.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -18.40, whereas VREX's P/E ratio is -8.46. In terms of profitability, BSGM's ROE is -35.30%, compared to VREX's ROE of -0.08%. Regarding short-term risk, BSGM is more volatile compared to VREX. This indicates potentially higher risk in terms of short-term price fluctuations for BSGM.
BSGM vs NPCE Comparison
BSGM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 266.1M. In comparison, NPCE has a market cap of 341.8M. Regarding current trading prices, BSGM is priced at $9.65, while NPCE trades at $10.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -18.40, whereas NPCE's P/E ratio is -12.71. In terms of profitability, BSGM's ROE is -35.30%, compared to NPCE's ROE of -1.40%. Regarding short-term risk, BSGM is more volatile compared to NPCE. This indicates potentially higher risk in terms of short-term price fluctuations for BSGM.
BSGM vs NNOX Comparison
BSGM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 266.1M. In comparison, NNOX has a market cap of 339.5M. Regarding current trading prices, BSGM is priced at $9.65, while NNOX trades at $5.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -18.40, whereas NNOX's P/E ratio is -5.85. In terms of profitability, BSGM's ROE is -35.30%, compared to NNOX's ROE of -0.31%. Regarding short-term risk, BSGM is more volatile compared to NNOX. This indicates potentially higher risk in terms of short-term price fluctuations for BSGM.
BSGM vs CLPT Comparison
BSGM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 266.1M. In comparison, CLPT has a market cap of 319.4M. Regarding current trading prices, BSGM is priced at $9.65, while CLPT trades at $11.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -18.40, whereas CLPT's P/E ratio is -14.87. In terms of profitability, BSGM's ROE is -35.30%, compared to CLPT's ROE of -0.78%. Regarding short-term risk, BSGM is more volatile compared to CLPT. This indicates potentially higher risk in terms of short-term price fluctuations for BSGM.
BSGM vs CERS Comparison
BSGM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 266.1M. In comparison, CERS has a market cap of 299.2M. Regarding current trading prices, BSGM is priced at $9.65, while CERS trades at $1.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -18.40, whereas CERS's P/E ratio is -15.65. In terms of profitability, BSGM's ROE is -35.30%, compared to CERS's ROE of -0.35%. Regarding short-term risk, BSGM is more volatile compared to CERS. This indicates potentially higher risk in terms of short-term price fluctuations for BSGM.
BSGM vs VMD Comparison
BSGM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 266.1M. In comparison, VMD has a market cap of 280.2M. Regarding current trading prices, BSGM is priced at $9.65, while VMD trades at $7.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -18.40, whereas VMD's P/E ratio is 23.63. In terms of profitability, BSGM's ROE is -35.30%, compared to VMD's ROE of +0.10%. Regarding short-term risk, BSGM is more volatile compared to VMD. This indicates potentially higher risk in terms of short-term price fluctuations for BSGM.
BSGM vs ZIMV Comparison
BSGM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 266.1M. In comparison, ZIMV has a market cap of 279.5M. Regarding current trading prices, BSGM is priced at $9.65, while ZIMV trades at $10.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -18.40, whereas ZIMV's P/E ratio is -11.12. In terms of profitability, BSGM's ROE is -35.30%, compared to ZIMV's ROE of -0.04%. Regarding short-term risk, BSGM is more volatile compared to ZIMV. This indicates potentially higher risk in terms of short-term price fluctuations for BSGM.
BSGM vs SNWV Comparison
BSGM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 266.1M. In comparison, SNWV has a market cap of 270.4M. Regarding current trading prices, BSGM is priced at $9.65, while SNWV trades at $31.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -18.40, whereas SNWV's P/E ratio is -5.07. In terms of profitability, BSGM's ROE is -35.30%, compared to SNWV's ROE of +1.00%. Regarding short-term risk, BSGM is more volatile compared to SNWV. This indicates potentially higher risk in terms of short-term price fluctuations for BSGM.
BSGM vs QTRX Comparison
BSGM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 266.1M. In comparison, QTRX has a market cap of 268.7M. Regarding current trading prices, BSGM is priced at $9.65, while QTRX trades at $6.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -18.40, whereas QTRX's P/E ratio is -5.58. In terms of profitability, BSGM's ROE is -35.30%, compared to QTRX's ROE of -0.15%. Regarding short-term risk, BSGM is more volatile compared to QTRX. This indicates potentially higher risk in terms of short-term price fluctuations for BSGM.
BSGM vs PTHL Comparison
BSGM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 266.1M. In comparison, PTHL has a market cap of 260.2M. Regarding current trading prices, BSGM is priced at $9.65, while PTHL trades at $18.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -18.40, whereas PTHL's P/E ratio is -365.20. In terms of profitability, BSGM's ROE is -35.30%, compared to PTHL's ROE of -0.30%. Regarding short-term risk, BSGM is more volatile compared to PTHL. This indicates potentially higher risk in terms of short-term price fluctuations for BSGM.
BSGM vs CATX Comparison
BSGM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 266.1M. In comparison, CATX has a market cap of 252.4M. Regarding current trading prices, BSGM is priced at $9.65, while CATX trades at $3.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -18.40, whereas CATX's P/E ratio is -2.76. In terms of profitability, BSGM's ROE is -35.30%, compared to CATX's ROE of -0.27%. Regarding short-term risk, BSGM is more volatile compared to CATX. This indicates potentially higher risk in terms of short-term price fluctuations for BSGM.
BSGM vs BWAY Comparison
BSGM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 266.1M. In comparison, BWAY has a market cap of 243.4M. Regarding current trading prices, BSGM is priced at $9.65, while BWAY trades at $12.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -18.40, whereas BWAY's P/E ratio is 58.55. In terms of profitability, BSGM's ROE is -35.30%, compared to BWAY's ROE of +0.06%. Regarding short-term risk, BSGM is more volatile compared to BWAY. This indicates potentially higher risk in terms of short-term price fluctuations for BSGM.
BSGM vs MXCT Comparison
BSGM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 266.1M. In comparison, MXCT has a market cap of 238.7M. Regarding current trading prices, BSGM is priced at $9.65, while MXCT trades at $2.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -18.40, whereas MXCT's P/E ratio is -5.61. In terms of profitability, BSGM's ROE is -35.30%, compared to MXCT's ROE of -0.20%. Regarding short-term risk, BSGM is more volatile compared to MXCT. This indicates potentially higher risk in terms of short-term price fluctuations for BSGM.
BSGM vs MASS Comparison
BSGM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 266.1M. In comparison, MASS has a market cap of 236.9M. Regarding current trading prices, BSGM is priced at $9.65, while MASS trades at $6.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -18.40, whereas MASS's P/E ratio is -2.98. In terms of profitability, BSGM's ROE is -35.30%, compared to MASS's ROE of -0.13%. Regarding short-term risk, BSGM is more volatile compared to MASS. This indicates potentially higher risk in terms of short-term price fluctuations for BSGM.
BSGM vs TCMD Comparison
BSGM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 266.1M. In comparison, TCMD has a market cap of 235.3M. Regarding current trading prices, BSGM is priced at $9.65, while TCMD trades at $10.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -18.40, whereas TCMD's P/E ratio is 15.33. In terms of profitability, BSGM's ROE is -35.30%, compared to TCMD's ROE of +0.08%. Regarding short-term risk, BSGM is more volatile compared to TCMD. This indicates potentially higher risk in terms of short-term price fluctuations for BSGM.
BSGM vs NVRO Comparison
BSGM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 266.1M. In comparison, NVRO has a market cap of 224.1M. Regarding current trading prices, BSGM is priced at $9.65, while NVRO trades at $5.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -18.40, whereas NVRO's P/E ratio is -1.91. In terms of profitability, BSGM's ROE is -35.30%, compared to NVRO's ROE of -0.43%. Regarding short-term risk, BSGM is more volatile compared to NVRO. This indicates potentially higher risk in terms of short-term price fluctuations for BSGM.
BSGM vs SGHT Comparison
BSGM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 266.1M. In comparison, SGHT has a market cap of 215.6M. Regarding current trading prices, BSGM is priced at $9.65, while SGHT trades at $4.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -18.40, whereas SGHT's P/E ratio is -4.26. In terms of profitability, BSGM's ROE is -35.30%, compared to SGHT's ROE of -0.55%. Regarding short-term risk, BSGM is more volatile compared to SGHT. This indicates potentially higher risk in terms of short-term price fluctuations for BSGM.
BSGM vs EYES Comparison
BSGM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 266.1M. In comparison, EYES has a market cap of 210M. Regarding current trading prices, BSGM is priced at $9.65, while EYES trades at $4.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -18.40, whereas EYES's P/E ratio is N/A. In terms of profitability, BSGM's ROE is -35.30%, compared to EYES's ROE of -0.26%. Regarding short-term risk, BSGM is more volatile compared to EYES. This indicates potentially higher risk in terms of short-term price fluctuations for BSGM.
BSGM vs INGN Comparison
BSGM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 266.1M. In comparison, INGN has a market cap of 199.2M. Regarding current trading prices, BSGM is priced at $9.65, while INGN trades at $7.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -18.40, whereas INGN's P/E ratio is -6.44. In terms of profitability, BSGM's ROE is -35.30%, compared to INGN's ROE of -0.15%. Regarding short-term risk, BSGM is more volatile compared to INGN. This indicates potentially higher risk in terms of short-term price fluctuations for BSGM.
BSGM vs TLSI Comparison
BSGM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 266.1M. In comparison, TLSI has a market cap of 185.3M. Regarding current trading prices, BSGM is priced at $9.65, while TLSI trades at $4.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -18.40, whereas TLSI's P/E ratio is -4.44. In terms of profitability, BSGM's ROE is -35.30%, compared to TLSI's ROE of +1.04%. Regarding short-term risk, BSGM is more volatile compared to TLSI. This indicates potentially higher risk in terms of short-term price fluctuations for BSGM.
BSGM vs PROF Comparison
BSGM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 266.1M. In comparison, PROF has a market cap of 183.3M. Regarding current trading prices, BSGM is priced at $9.65, while PROF trades at $6.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -18.40, whereas PROF's P/E ratio is -5.04. In terms of profitability, BSGM's ROE is -35.30%, compared to PROF's ROE of -0.70%. Regarding short-term risk, BSGM is more volatile compared to PROF. This indicates potentially higher risk in terms of short-term price fluctuations for BSGM.
BSGM vs ELMD Comparison
BSGM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 266.1M. In comparison, ELMD has a market cap of 170.5M. Regarding current trading prices, BSGM is priced at $9.65, while ELMD trades at $20.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -18.40, whereas ELMD's P/E ratio is 25.73. In terms of profitability, BSGM's ROE is -35.30%, compared to ELMD's ROE of +0.17%. Regarding short-term risk, BSGM is more volatile compared to ELMD. This indicates potentially higher risk in terms of short-term price fluctuations for BSGM.
BSGM vs CVRX Comparison
BSGM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 266.1M. In comparison, CVRX has a market cap of 168.4M. Regarding current trading prices, BSGM is priced at $9.65, while CVRX trades at $6.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -18.40, whereas CVRX's P/E ratio is -3.02. In terms of profitability, BSGM's ROE is -35.30%, compared to CVRX's ROE of -0.79%. Regarding short-term risk, BSGM is more volatile compared to CVRX. This indicates potentially higher risk in terms of short-term price fluctuations for BSGM.
BSGM vs ANIK Comparison
BSGM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 266.1M. In comparison, ANIK has a market cap of 161.3M. Regarding current trading prices, BSGM is priced at $9.65, while ANIK trades at $11.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -18.40, whereas ANIK's P/E ratio is -15.00. In terms of profitability, BSGM's ROE is -35.30%, compared to ANIK's ROE of -0.33%. Regarding short-term risk, BSGM is more volatile compared to ANIK. This indicates potentially higher risk in terms of short-term price fluctuations for BSGM.
BSGM vs LNSR Comparison
BSGM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 266.1M. In comparison, LNSR has a market cap of 155.6M. Regarding current trading prices, BSGM is priced at $9.65, while LNSR trades at $13.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -18.40, whereas LNSR's P/E ratio is -2.69. In terms of profitability, BSGM's ROE is -35.30%, compared to LNSR's ROE of -5.28%. Regarding short-term risk, BSGM is more volatile compared to LNSR. This indicates potentially higher risk in terms of short-term price fluctuations for BSGM.
BSGM vs RPID Comparison
BSGM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 266.1M. In comparison, RPID has a market cap of 153.8M. Regarding current trading prices, BSGM is priced at $9.65, while RPID trades at $3.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -18.40, whereas RPID's P/E ratio is -3.41. In terms of profitability, BSGM's ROE is -35.30%, compared to RPID's ROE of -0.56%. Regarding short-term risk, BSGM is more volatile compared to RPID. This indicates potentially higher risk in terms of short-term price fluctuations for BSGM.
BSGM vs AVR Comparison
BSGM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 266.1M. In comparison, AVR has a market cap of 138.4M. Regarding current trading prices, BSGM is priced at $9.65, while AVR trades at $3.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -18.40, whereas AVR's P/E ratio is -1.07. In terms of profitability, BSGM's ROE is -35.30%, compared to AVR's ROE of -2.92%. Regarding short-term risk, BSGM is more volatile compared to AVR. This indicates potentially higher risk in terms of short-term price fluctuations for BSGM.
BSGM vs OWLT Comparison
BSGM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 266.1M. In comparison, OWLT has a market cap of 137M. Regarding current trading prices, BSGM is priced at $9.65, while OWLT trades at $8.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -18.40, whereas OWLT's P/E ratio is -5.15. In terms of profitability, BSGM's ROE is -35.30%, compared to OWLT's ROE of +1.25%. Regarding short-term risk, BSGM is more volatile compared to OWLT. This indicates potentially higher risk in terms of short-term price fluctuations for BSGM.
BSGM vs BDMD Comparison
BSGM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 266.1M. In comparison, BDMD has a market cap of 136.8M. Regarding current trading prices, BSGM is priced at $9.65, while BDMD trades at $3.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -18.40, whereas BDMD's P/E ratio is 7.82. In terms of profitability, BSGM's ROE is -35.30%, compared to BDMD's ROE of +0.12%. Regarding short-term risk, BSGM is more volatile compared to BDMD. This indicates potentially higher risk in terms of short-term price fluctuations for BSGM.
BSGM vs RCEL Comparison
BSGM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 266.1M. In comparison, RCEL has a market cap of 136.5M. Regarding current trading prices, BSGM is priced at $9.65, while RCEL trades at $5.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -18.40, whereas RCEL's P/E ratio is -2.36. In terms of profitability, BSGM's ROE is -35.30%, compared to RCEL's ROE of -3.38%. Regarding short-term risk, BSGM is more volatile compared to RCEL. This indicates potentially higher risk in terms of short-term price fluctuations for BSGM.
BSGM vs LUCD Comparison
BSGM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 266.1M. In comparison, LUCD has a market cap of 113.1M. Regarding current trading prices, BSGM is priced at $9.65, while LUCD trades at $1.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -18.40, whereas LUCD's P/E ratio is -0.89. In terms of profitability, BSGM's ROE is -35.30%, compared to LUCD's ROE of +26.96%. Regarding short-term risk, BSGM is more volatile compared to LUCD. This indicates potentially higher risk in terms of short-term price fluctuations for BSGM.
BSGM vs LUNG Comparison
BSGM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 266.1M. In comparison, LUNG has a market cap of 109.9M. Regarding current trading prices, BSGM is priced at $9.65, while LUNG trades at $2.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -18.40, whereas LUNG's P/E ratio is -1.90. In terms of profitability, BSGM's ROE is -35.30%, compared to LUNG's ROE of -0.64%. Regarding short-term risk, BSGM is more volatile compared to LUNG. This indicates potentially higher risk in terms of short-term price fluctuations for BSGM.
BSGM vs MGRM Comparison
BSGM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 266.1M. In comparison, MGRM has a market cap of 103.9M. Regarding current trading prices, BSGM is priced at $9.65, while MGRM trades at $2.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -18.40, whereas MGRM's P/E ratio is -5.82. In terms of profitability, BSGM's ROE is -35.30%, compared to MGRM's ROE of -1.26%. Regarding short-term risk, BSGM is more volatile compared to MGRM. This indicates potentially higher risk in terms of short-term price fluctuations for BSGM.
BSGM vs ICAD Comparison
BSGM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 266.1M. In comparison, ICAD has a market cap of 102.5M. Regarding current trading prices, BSGM is priced at $9.65, while ICAD trades at $3.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -18.40, whereas ICAD's P/E ratio is -19.63. In terms of profitability, BSGM's ROE is -35.30%, compared to ICAD's ROE of -0.17%. Regarding short-term risk, BSGM is more volatile compared to ICAD. This indicates potentially higher risk in terms of short-term price fluctuations for BSGM.
BSGM vs HJLI Comparison
BSGM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BSGM stands at 266.1M. In comparison, HJLI has a market cap of 98.3M. Regarding current trading prices, BSGM is priced at $9.65, while HJLI trades at $10.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BSGM currently has a P/E ratio of -18.40, whereas HJLI's P/E ratio is N/A. In terms of profitability, BSGM's ROE is -35.30%, compared to HJLI's ROE of -0.51%. Regarding short-term risk, BSGM is more volatile compared to HJLI. This indicates potentially higher risk in terms of short-term price fluctuations for BSGM.